Skip to main content

Meng Li, PhD

Houston, TX
United States

MD Anderson Cancer Center

Dr. Meng Li is an Assistant Professor at the Department of Health Services Research at the UT MD Anderson Cancer Center and a nonresident fellow at the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern California. Dr. Li completed her PhD in Pharmaceutical Outcomes Research and Policy at University of Washington, where co-PI, Dr. Flowers also completed his MS. Dr. Li’s research uses various data sources including population-based cancer registries, nationwide administrative claims databases, national survey data, and data from clinical trials and observational series to examine disease burden, factors that influence health care utilization, the effect of health care utilization on health outcomes, and the cost-sharing burden of prescription drugs. In particular, Her research has used Optum and SEER-Medicare data to examine disparity in initiation of immunotherapies among lung cancer and melanoma patients, the association between spending on several types of treatment and outcomes in breast cancer, and catastrophic spending among cancer patients on oral targeted anticancer medicines. Dr. Li has also developed methods to quantify novel elements of value for medical technologies in economic evaluations, which has important implications on the practice of value assessment. She meets regularly and collaborates with Drs. Shih and Flowers. Dr. Li’s research work has been published in top clinical, health economics, and health policy journals.

Program Name(s)
Equity in Access
Dr. Li